PURCHASE AGREEMENT ASTERIAS BIOTHERAPEUTICS, INC. 1,000,000 BioTime Inc. Common Shares with 1,000,000 Asterias Series B Common Stock Purchase Warrants Total Purchase Price $2,500,000 READ THIS AGREEMENT CAREFULLY BEFORE YOU INVESTPurchase Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
This Agreement is entered into by Broadwood Partners, L.P. (“Purchaser”) and Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
THIS REGISTRATION RIGHTS AGREEMENT, dated as of June 16, 2014, is made by and among Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each Shareholder (as defined below) who is the registered holder of Registrable Securities (as defined below).
STOCK PURCHASE AGREEMENT ASTERIAS BIOTHERAPEUTICS, INC. READ THIS AGREEMENT CAREFULLY BEFORE YOU INVESTStock Purchase Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
This Stock Purchase Agreement (“Agreement”) is entered into by Pedro Lichtinger (“Purchaser”) and Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company).
EMPLOYMENT AGREEMENTEmployment Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made as of June 9, 2014 by and between Asterias Biotherapeutics, Inc. (“Asterias”), a Delaware corporation, and Pedro Lichtinger ("Executive").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
STOCK OPTION AGREEMENTStock Option Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
THIS AGREEMENT made and entered into as of __________, by and between LIFEMAP SOLUTIONS, INC.., a Delaware corporation (the "Company"), and ______________, an employee or consultant (the "Optionee") of the Company or of a subsidiary of the Company (hereinafter included within the term "Company") within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the "Code"),
INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • California
THIS AGREEMENT made and entered into as of __________, by and between LIFEMAP SOLUTIONS, INC.., a Delaware corporation (the "Company"), and ______________, an employee/consultant (the "Employee") of the Company or of a subsidiary of the Company (hereinafter included within the term "Company") within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the "Code"),
CO-DEVELOPMENT AND OPTION AGREEMENTCo-Development and Option Agreement • August 11th, 2014 • Biotime Inc • Biological products, (no disgnostic substances) • New York
This Co-development and Option Agreement (“Agreement”) is made by and between the Icahn School of Medicine at Mount Sinai, a nonprofit education corporation organized and existing under the laws of the State of New York, having an office at One Gustave L. Levy Place, New York, New York 10029 (“Mount Sinai”), and LifeMap Solutions, Inc., a corporation organized and existing under the laws of Delaware (“LifeMap”), having a place of business at 1301 Bay Harbor Parkway, Suite 100, Alameda, CA 94502. Mount Sinai and LifeMap are each referred to herein as a “Party” and collectively, as the “Parties.”
